Read + Share
Kim J, Noh JJ, Lee TK, Kim SI, et al. Real-world experience of pembrolizumab and lenvatinib in recurrent endometrial
cancer: A multicenter study in Korea. Gynecol Oncol 2022 Mar 8. pii: S0090-8258(22)00140.
PMID: 35277278
|
 |
|
Kim J, Noh JJ, Lee TK, Kim SI, et al. Real-world experience of pembrolizumab and lenvatinib in recurrent endometrial
cancer: A multicenter study in Korea. Gynecol Oncol 2022 Mar 8. pii: S0090-8258(22)00140.
PMID: 35277278
|
|
|
|